UNSPSC 51283611: Rifamycin sodium

This classification denotes an antitubercular agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 32086GS35Z. European Medicines Agency schedules Rifamycin sodium in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB04246MIG. Rifamycin sodium generally arises in the molecular formula C37H46NO12.NA. The term 'rifamycin sodium' is a United States Adopted Name designation. Most nations, for tariff and trade purposes, schedule rifamycin sodium under HS 29419000 and SITC 54139.

UNSPSC 51283611 Rifamycin sodium is a Commodity code for a specific antibiotic pharmaceutical product, yet the most recent state and local contract opportunities posted under this code show little relevant purchasing activity. The two records in the recent-opportunities block—an Illinois Department of Public Health piggyback pharmaceutical warehouse contract awarded to Chartwell Rx LLC for Doxycycline Hyclate and Ciprofloxacin Hydrochloride, and a Seminole County, Florida IFB for Naloxone and Safe Drug Deactivation Systems—do not involve rifamycin sodium procurement. The mismatch suggests either miscoding in the source data or that state and local governments are not currently soliciting rifamycin sodium as a standalone line item under this code. When state and local procurement offices do buy pharmaceutical products, they typically use cooperative purchasing vehicles such as MMCAP Infuse consortiums and piggyback contracts to leverage incumbent vendor relationships and negotiate volume pricing; however, no rifamycin sodium activity appears in the recent record.

Without active solicitations under this code, no issuing-body mix, geographic concentration, or representative recent opportunities can be drawn from the source. The Illinois Department of Public Health and Seminole County represent state health departments and counties as potential buyers of pharmaceutical products generally, but they are not currently procuring rifamycin sodium through visible state and local notices. Firms pursuing opportunities under this code should monitor cooperative purchasing catalogs and state pharmaceutical supply contracts to detect when rifamycin sodium is added to existing vehicle lineups.